129 related articles for article (PubMed ID: 18246671)
1. Differentiation between benign prostatic hyperplasia and prostate cancer in the transitional zone evaluated by 1H magnetic resonance spectroscopic imaging.
Li SY; Chen M; Wang R; Zhou C
Chin Med Sci J; 2007 Dec; 22(4):238-42. PubMed ID: 18246671
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
Kurhanewicz J; Vigneron DB; Hricak H; Narayan P; Carroll P; Nelson SJ
Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874
[TBL] [Abstract][Full Text] [Related]
3. 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation.
Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX
Eur J Radiol; 2010 Feb; 73(2):345-51. PubMed ID: 19070978
[TBL] [Abstract][Full Text] [Related]
4. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy.
Kurhanewicz J; Vigneron DB; Nelson SJ; Hricak H; MacDonald JM; Konety B; Narayan P
Urology; 1995 Mar; 45(3):459-66. PubMed ID: 7533458
[TBL] [Abstract][Full Text] [Related]
5. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results.
Zakian KL; Eberhardt S; Hricak H; Shukla-Dave A; Kleinman S; Muruganandham M; Sircar K; Kattan MW; Reuter VE; Scardino PT; Koutcher JA
Radiology; 2003 Oct; 229(1):241-7. PubMed ID: 12920178
[TBL] [Abstract][Full Text] [Related]
6. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines.
Shukla-Dave A; Hricak H; Moskowitz C; Ishill N; Akin O; Kuroiwa K; Spector J; Kumar M; Reuter VE; Koutcher JA; Zakian KL
Radiology; 2007 Nov; 245(2):499-506. PubMed ID: 17890357
[TBL] [Abstract][Full Text] [Related]
7. In vivo differential diagnosis of prostate cancer and benign prostatic hyperplasia: localized proton magnetic resonance spectroscopy using external-body surface coil.
Kim JK; Kim DY; Lee YH; Sung NK; Chung DS; Kim OD; Kim KB
Magn Reson Imaging; 1998 Dec; 16(10):1281-8. PubMed ID: 9858286
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional proton magnetic resonance spectroscopic imaging with and without an endorectal coil: a prostate phantom study.
Ma C; Chen L; Scheenen TW; Lu J; Wang J
Acta Radiol; 2015 Nov; 56(11):1342-9. PubMed ID: 25348479
[TBL] [Abstract][Full Text] [Related]
9. [Characterization of prostate cancer, benign prostatic hyperplasia and normal prostates using endorectal 1H magnetic resonance spectroscopy].
Saikawa S; Suzuki Y; Tomoi M; Yoshida M; Ishii Y; Okada K
Nihon Hinyokika Gakkai Zasshi; 1995 Nov; 86(11):1673-80. PubMed ID: 8551711
[TBL] [Abstract][Full Text] [Related]
10. In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue.
Heerschap A; Jager GJ; van der Graaf M; Barentsz JO; de la Rosette JJ; Oosterhof GO; Ruijter ET; Ruijs SH
Anticancer Res; 1997; 17(3A):1455-60. PubMed ID: 9179183
[TBL] [Abstract][Full Text] [Related]
11. [Spectroscopic imaging (1H-2D-CSI) of the prostate: sequence optimization and correlation with histopathological results].
Stanka M; Eltze E; Semjonow A; Sievert KD; Maier A; Pfleiderer B
Rofo; 2000 Jul; 172(7):623-9. PubMed ID: 10962989
[TBL] [Abstract][Full Text] [Related]
12. Contribution of Histopathologic Tissue Composition to Quantitative MR Spectroscopy and Diffusion-weighted Imaging of the Prostate.
Kobus T; van der Laak JA; Maas MC; Hambrock T; Bruggink CC; Hulsbergen-van de Kaa CA; Scheenen TW; Heerschap A
Radiology; 2016 Mar; 278(3):801-11. PubMed ID: 26418614
[TBL] [Abstract][Full Text] [Related]
13. In vivo proton magnetic resonance spectroscopy of diseased prostate: spectroscopic features of malignant versus benign pathology.
García-Segura JM; Sánchez-Chapado M; Ibarburen C; Viaño J; Angulo JC; González J; Rodríguez-Vallejo JM
Magn Reson Imaging; 1999 Jun; 17(5):755-65. PubMed ID: 10372529
[TBL] [Abstract][Full Text] [Related]
14. Metabolite ratios in 1H MR spectroscopic imaging of the prostate.
Kobus T; Wright AJ; Weiland E; Heerschap A; Scheenen TW
Magn Reson Med; 2015 Jan; 73(1):1-12. PubMed ID: 24488656
[TBL] [Abstract][Full Text] [Related]
15. PSA density and PSA transition zone density in the diagnosis of prostate cancer in PSA gray zone cases.
Aksoy Y; Oral A; Aksoy H; Demirel A; Akcay F
Ann Clin Lab Sci; 2003; 33(3):320-3. PubMed ID: 12956448
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging.
Kurhanewicz J; Vigneron DB; Hricak H; Parivar F; Nelson SJ; Shinohara K; Carroll PR
Radiology; 1996 Aug; 200(2):489-96. PubMed ID: 8685346
[TBL] [Abstract][Full Text] [Related]
17. High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features--initial experience.
Hom JJ; Coakley FV; Simko JP; Lu Y; Qayyum A; Westphalen AC; Schmitt LD; Carroll PR; Kurhanewicz J
Radiology; 2007 Feb; 242(2):483-9. PubMed ID: 17179396
[TBL] [Abstract][Full Text] [Related]
18. In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil.
Kobus T; Hambrock T; Hulsbergen-van de Kaa CA; Wright AJ; Barentsz JO; Heerschap A; Scheenen TW
Eur Urol; 2011 Nov; 60(5):1074-80. PubMed ID: 21419565
[TBL] [Abstract][Full Text] [Related]
19. Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging.
Coakley FV; Chen I; Qayyum A; Westphalen AC; Carroll PR; Hricak H; Chen MH; Kurhanewicz J
BJU Int; 2007 Jan; 99(1):41-5. PubMed ID: 17227490
[TBL] [Abstract][Full Text] [Related]
20. Prostate specific antigen density for discriminating prostate cancer from benign prostatic hyperplasia in the gray zone of prostate-specific antigen.
Uno H; Koide T; Kuriyama M; Ban Y; Deguchi T; Kawada Y
Hinyokika Kiyo; 1999 Jul; 45(7):457-61. PubMed ID: 10466060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
